S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 

Pfizer (PFE) Short Interest Ratio & Short Volume

$28.78
+0.15 (+0.52%)
(As of 12/8/2023 ET)
Compare
Today's Range
$28.59
$28.97
50-Day Range
$28.62
$33.94
52-Week Range
$28.30
$54.93
Volume
31.26 million shs
Average Volume
34.12 million shs
Market Capitalization
$162.50 billion
P/E Ratio
15.73
Dividend Yield
5.70%
Price Target
$42.50

Pfizer Short Interest Data

Current Short Volume
57,500,000 shares
Previous Short Volume
47,180,000 shares
Change Vs. Previous Month
+21.87%
Dollar Volume Sold Short
$1.74 billion
Short Interest Ratio / Days to Cover
2.0
Last Record Date
November 15, 2023
Outstanding Shares
5,646,410,000 shares
Percentage of Shares Shorted
1.02%
Today's Trading Volume
31,257,168 shares
Average Trading Volume
34,122,536 shares
Today's Volume Vs. Average
92%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Pfizer ?

Sign up to receive the latest short interest report for Pfizer and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PFE Short Interest Over Time

PFE Days to Cover Over Time

PFE Percentage of Float Shorted Over Time


Pfizer Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202357,500,000 shares $1.74 billion +21.9%N/A2 $30.19
10/31/202347,180,000 shares $1.44 billion -13.5%N/A1.8 $30.56
10/15/202354,570,000 shares $1.75 billion +6.8%N/A2 $32.11
9/30/202351,080,000 shares $1.69 billion +2.3%N/A2.1 $33.17
9/15/202349,950,000 shares $1.70 billion -1.0%N/A2 $34.03
8/31/202350,460,000 shares $1.79 billion -3.7%N/A2.1 $35.38
8/15/202352,390,000 shares $1.85 billion +14.2%N/A1.9 $35.39
7/31/202345,860,000 shares $1.65 billion -13.0%N/A1.7 $36.06
7/15/202352,680,000 shares $1.91 billion -11.5%N/A2 $36.32
6/30/202359,510,000 shares $2.18 billion +8.0%N/A2.3 $36.68
6/15/202355,120,000 shares $2.19 billion -1.2%N/A2.2 $39.77
5/31/202355,780,000 shares $2.12 billion +21.5%N/A2.3 $38.02
5/15/202345,920,000 shares $1.71 billion +4.7%N/A1.9 $37.16
4/30/202343,870,000 shares $1.71 billion +6.0%N/A2.1 $38.89
4/15/202341,370,000 shares $1.70 billion -15.7%N/A1.9 $41.19
3/31/202349,070,000 shares $2.00 billion +11.2%N/A2.1 $40.80
3/15/202344,140,000 shares $1.78 billion +14.7%N/A2 $40.28
2/28/202338,490,000 shares $1.56 billion +1.2%N/A1.7 $40.57
2/15/202338,020,000 shares $1.65 billion -2.9%N/A1.7 $43.32
1/31/202339,170,000 shares $1.73 billion +5.4%N/A1.8 $44.16
1/15/202337,170,000 shares $1.78 billion -12.6%N/A1.7 $47.85
12/30/202242,530,000 shares $2.18 billion -26.7%N/A2 $51.24
12/15/202258,020,000 shares $3.11 billion -7.7%N/A2.7 $53.61
11/30/202262,830,000 shares $3.15 billion -10.3%N/A3.1 $50.13
11/15/202270,040,000 shares $3.40 billion +28.1%N/A3.6 $48.57
10/31/202254,690,000 shares $2.55 billion -12.5%N/A2.7 $46.55
10/15/202262,510,000 shares $2.68 billion +3.5%N/A3.2 $42.86
9/30/202260,370,000 shares $2.64 billion -5.5%N/A3.3 $43.76
9/15/202263,890,000 shares $2.94 billion +2.7%N/A3.6 $45.94
8/31/202262,200,000 shares $2.81 billion -8.5%N/A3.3 $45.23
8/15/202267,940,000 shares $3.38 billion +13.4%N/A3.4 $49.75
7/31/202259,900,000 shares $3.03 billion -11.1%N/A2.9 $50.51
7/15/202267,350,000 shares $3.49 billion -2.3%N/A3 $51.75
6/30/202268,930,000 shares $3.61 billion -10.5%N/A2.9 $52.43
6/15/202276,980,000 shares $3.73 billion -0.3%N/A3.1 $48.51
5/31/202277,200,000 shares $4.09 billion +33.9%N/A2.9 $53.04
5/15/202257,670,000 shares $2.88 billion -15.2%N/A2.1 $49.92
4/30/202267,990,000 shares $3.34 billion +8.5%N/A2.3 $49.07
4/15/202262,650,000 shares $3.33 billion +1.8%N/A2 $53.12
3/31/202261,560,000 shares $3.19 billion +0.6%N/A1.9 $51.77













PFE Short Interest - Frequently Asked Questions

What is Pfizer's current short interest?

Short interest is the volume of Pfizer shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 57,500,000 shares of PFE short. Learn More on Pfizer's current short interest.

What is a good short interest ratio for Pfizer?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PFE shares currently have a short interest ratio of 2.0. Learn More on Pfizer's short interest ratio.

Which institutional investors are shorting Pfizer?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Citigroup Inc., Walleye Trading LLC, Walleye Capital LLC, Creative Planning, GTS Securities LLC, Tudor Investment Corp Et Al, Wolverine Trading LLC, Jag Capital Management LLC, Royal Bank of Canada, JPMorgan Chase & Co., Laurion Capital Management LP, Schonfeld Strategic Advisors LLC, Capital Markets Trading UK LLP, Tyler Stone Wealth Management, Private Capital Management LLC, Nomura Holdings Inc., Qube Research & Technologies Ltd, Marathon Trading Investment Management LLC, PEAK6 Investments LLC, Eisler Capital UK Ltd., Eisler Capital US LLC, LPL Financial LLC, Clear Street Markets LLC, Delta Accumulation LLC, Wolverine Asset Management LLC, Maven Securities LTD, HAP Trading LLC, Group One Trading L.P., Citigroup Inc., UBS Group AG, HighTower Advisors LLC, Cutler Group LLC CA, Capula Management Ltd, US Bancorp DE, Simplex Trading LLC, XR Securities LLC, Concourse Financial Group Securities Inc., Traynor Capital Management Inc., SG Americas Securities LLC, FNY Investment Advisers LLC, National Bank of Canada FI, and Gladius Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Pfizer's short interest increasing or decreasing?

Pfizer saw a increase in short interest in November. As of November 15th, there was short interest totaling 57,500,000 shares, an increase of 21.9% from the previous total of 47,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Pfizer's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Pfizer: Bristol-Myers Squibb (1.32%), Zoetis Inc. (0.66%), AbbVie Inc. (0.63%), Merck & Co., Inc. (0.71%), Johnson & Johnson (0.55%), Eli Lilly and Company (0.69%), Abbott Laboratories (0.70%), AstraZeneca PLC (0.26%), Novartis AG (0.19%), Sanofi (0.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Pfizer stock?

Short selling PFE is an investing strategy that aims to generate trading profit from Pfizer as its price is falling. PFE shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Pfizer?

A short squeeze for Pfizer occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PFE, which in turn drives the price of the stock up even further.

How often is Pfizer's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PFE, twice per month. The most recent reporting period available is November, 15 2023.



More Short Interest Resources from MarketBeat

This page (NYSE:PFE) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -